Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 103 entries
Sorted by: Best Match Show Resources per page
Exposing students to STEM careers through hands-on activities with drones and robots

STEM and "broadening participation"

Alberts TE, Jovanović VM, McLeod G, Tomovic C.
GSID: 5-Wcn1OWYrUJ
VM Jovanović, G McLeod, TE Alberts, C Tomovic… - 2019 - digitalcommons.odu.edu

… research in broadening participation efforts of underrepresented students in STEM funded by … to nine graders that focus on broadening participation of underrepresented students into …

Cite
Jovanović, V. M., McLeod, G., Alberts, T. E., Tomovic, C., Popescu, O., Batts, T., ... & Louise, M. (2019). Exposing students to STEM careers through hands-on activities with drones and robots.
Jovanović, Vukica M., et al. "Exposing students to STEM careers through hands-on activities with drones and robots." (2019).
Copy Download .nbib Format: MLA
Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterol.

Patient preference and adherence

Albertson TE, Harper R, Murin S, Sandrock C.
PMID: 25673975
Patient Prefer Adherence. 2015 Feb 02;9:235-42. doi: 10.2147/PPA.S71535. eCollection 2015.

Medication adherence among patients with chronic diseases, such as COPD, may be suboptimal, and many factors contribute to this poor adherence. One major factor is the frequency of medication dosing. Once-daily dosing has been shown to be an important...

Cite
Albertson TE, Harper R, Murin S, et al. Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterol. Patient Prefer Adherence. 2015;9:235-42doi: 10.2147/PPA.S71535.
Albertson, T. E., Harper, R., Murin, S., & Sandrock, C. (2015). Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterol. Patient preference and adherence, 9235-42. https://doi.org/10.2147/PPA.S71535
Albertson, Timothy E, et al. "Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterol." Patient preference and adherence vol. 9 (2015): 235-42. doi: https://doi.org/10.2147/PPA.S71535
Albertson TE, Harper R, Murin S, Sandrock C. Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterol. Patient Prefer Adherence. 2015 Feb 02;9:235-42. doi: 10.2147/PPA.S71535. eCollection 2015. PMID: 25673975; PMCID: PMC4321647.
Copy Download .nbib Format: NLM
Constraint and diversification of developmental trajectories in cichlid facial morphologies.

EvoDevo

Powder KE, Milch K, Asselin G, Albertson RC.
PMID: 26225206
Evodevo. 2015 Jun 28;6:25. doi: 10.1186/s13227-015-0020-8. eCollection 2015.

BACKGROUND: A major goal of evolutionary biology is to understand the origins of phenotypic diversity. Changes in development, for instance heterochrony, can be a potent source of phenotypic variation. On the other hand, development can also constrain the spectrum...

Cite
Powder KE, Milch K, Asselin G, et al. Constraint and diversification of developmental trajectories in cichlid facial morphologies. Evodevo. 2015;6:25doi: 10.1186/s13227-015-0020-8.
Powder, K. E., Milch, K., Asselin, G., & Albertson, R. C. (2015). Constraint and diversification of developmental trajectories in cichlid facial morphologies. EvoDevo, 625. https://doi.org/10.1186/s13227-015-0020-8
Powder, Kara E, et al. "Constraint and diversification of developmental trajectories in cichlid facial morphologies." EvoDevo vol. 6 (2015): 25. doi: https://doi.org/10.1186/s13227-015-0020-8
Powder KE, Milch K, Asselin G, Albertson RC. Constraint and diversification of developmental trajectories in cichlid facial morphologies. Evodevo. 2015 Jun 28;6:25. doi: 10.1186/s13227-015-0020-8. eCollection 2015. PMID: 26225206; PMCID: PMC4518560.
Copy Download .nbib Format: NLM
Effectiveness of structured, hospital-based, nurse-led atrial fibrillation clinics: a comparison between a real-world population and a clinical trial population.

Open heart

Qvist I, Hendriks JM, Møller DS, Albertsen AE, Mogensen HM, Oddershede GD, Odgaard A, Mortensen LS, Johnsen SP, Frost L.
PMID: 26835143
Open Heart. 2016 Jan 13;3(1):e000335. doi: 10.1136/openhrt-2015-000335. eCollection 2016.

OBJECTIVE: A previous randomised trial showed that structured, nurse-led atrial fibrillation (AF) care is superior to conventional AF care, although further research is needed to determine the outcomes of such care in a real-world setting. We compared the outcomes...

Cite
Qvist I, Hendriks JM, Møller DS, et al. Effectiveness of structured, hospital-based, nurse-led atrial fibrillation clinics: a comparison between a real-world population and a clinical trial population. Open Heart. 2016;3(1):e000335doi: 10.1136/openhrt-2015-000335.
Qvist, I., Hendriks, J. M., Møller, D. S., Albertsen, A. E., Mogensen, H. M., Oddershede, G. D., Odgaard, A., Mortensen, L. S., Johnsen, S. P., & Frost, L. (2016). Effectiveness of structured, hospital-based, nurse-led atrial fibrillation clinics: a comparison between a real-world population and a clinical trial population. Open heart, 3(1), e000335. https://doi.org/10.1136/openhrt-2015-000335
Qvist, Ina, et al. "Effectiveness of structured, hospital-based, nurse-led atrial fibrillation clinics: a comparison between a real-world population and a clinical trial population." Open heart vol. 3,1 (2016): e000335. doi: https://doi.org/10.1136/openhrt-2015-000335
Qvist I, Hendriks JM, Møller DS, Albertsen AE, Mogensen HM, Oddershede GD, Odgaard A, Mortensen LS, Johnsen SP, Frost L. Effectiveness of structured, hospital-based, nurse-led atrial fibrillation clinics: a comparison between a real-world population and a clinical trial population. Open Heart. 2016 Jan 13;3(1):e000335. doi: 10.1136/openhrt-2015-000335. eCollection 2016. PMID: 26835143; PMCID: PMC4716448.
Copy Download .nbib Format: NLM
[In Process Citation].

Ugeskrift for laeger

Albertsen AE.
PMID: 26561667
Ugeskr Laeger. 2015 Aug 17;177(34):1652-3.

No abstract available.

Cite
Albertsen AE. Svar: Bekymringer unødvendige. [In Process Citation]. Ugeskr Laeger. 2015;177(34):1652-3
Albertsen, A. E. (2015). Svar: Bekymringer unødvendige. [In Process Citation]. Ugeskrift for laeger, 177(34), 1652-3.
Albertsen, Andi Eie. "Svar: Bekymringer unødvendige." [In Process Citation]. Ugeskrift for laeger vol. 177,34 (2015): 1652-3.
Albertsen AE. Svar: Bekymringer unødvendige. [In Process Citation]. Ugeskr Laeger. 2015 Aug 17;177(34):1652-3. Danish. PMID: 26561667.
Copy Download .nbib Format: NLM
Correction: the impact of host diet on wolbachia titer in Drosophila.

PLoS pathogens

Serbus LR, White PM, Silva JP, Rabe A, Teixeira L, Albertson R, Sullivan W.
PMID: 25961733
PLoS Pathog. 2015 May 11;11(5):e1004889. doi: 10.1371/journal.ppat.1004889. eCollection 2015 May.

No abstract available.

Cite
Serbus LR, White PM, Silva JP, et al. Correction: the impact of host diet on wolbachia titer in Drosophila. PLoS Pathog. 2015;11(5):e1004889doi: 10.1371/journal.ppat.1004889.
Serbus, L. R., White, P. M., Silva, J. P., Rabe, A., Teixeira, L., Albertson, R., & Sullivan, W. (2015). Correction: the impact of host diet on wolbachia titer in Drosophila. PLoS pathogens, 11(5), e1004889. https://doi.org/10.1371/journal.ppat.1004889
Serbus, Laura R, et al. "Correction: the impact of host diet on wolbachia titer in Drosophila." PLoS pathogens vol. 11,5 (2015): e1004889. doi: https://doi.org/10.1371/journal.ppat.1004889
Serbus LR, White PM, Silva JP, Rabe A, Teixeira L, Albertson R, Sullivan W. Correction: the impact of host diet on wolbachia titer in Drosophila. PLoS Pathog. 2015 May 11;11(5):e1004889. doi: 10.1371/journal.ppat.1004889. eCollection 2015 May. PMID: 25961733; PMCID: PMC4427498.
Copy Download .nbib Format: NLM
Pulmonary cystic disease associated with integumentary and renal manifestations.

Journal of biomedical research

Cayetano KS, Albertson TE, Chan AL.
PMID: 24285950
J Biomed Res. 2013 Nov;27(6):515-9. doi: 10.7555/JBR.27.20130079. Epub 2013 Oct 28.

A 69-year-old man with multiple skin lesions on his face, neck and upper torso, which first appeared in the 3rd decade of his life, was admitted to our hospital. He had cystic changes in his lungs noted on chest...

Cite
Cayetano KS, Albertson TE, Chan AL. Pulmonary cystic disease associated with integumentary and renal manifestations. J Biomed Res. 2013;27(6):515-9doi: 10.7555/JBR.27.20130079.
Cayetano, K. S., Albertson, T. E., & Chan, A. L. (2013). Pulmonary cystic disease associated with integumentary and renal manifestations. Journal of biomedical research, 27(6), 515-9. https://doi.org/10.7555/JBR.27.20130079
Cayetano, Katherine S, et al. "Pulmonary cystic disease associated with integumentary and renal manifestations." Journal of biomedical research vol. 27,6 (2013): 515-9. doi: https://doi.org/10.7555/JBR.27.20130079
Cayetano KS, Albertson TE, Chan AL. Pulmonary cystic disease associated with integumentary and renal manifestations. J Biomed Res. 2013 Nov;27(6):515-9. doi: 10.7555/JBR.27.20130079. Epub 2013 Oct 28. PMID: 24285950; PMCID: PMC3841477.
Copy Download .nbib Format: NLM
9.9-Difluorofluorene.

Journal of the American Chemical Society

RAY FE, ALBERTSON CE.
PMID: 18861828
J Am Chem Soc. 1948 May;70(5):1954. doi: 10.1021/ja01185a091.

No abstract available.

Cite
RAY FE, ALBERTSON CE. 9.9-Difluorofluorene. J Am Chem Soc. 1948;70(5):1954doi: 10.1021/ja01185a091.
RAY, F. E., & ALBERTSON, C. E. (1948). 9.9-Difluorofluorene. Journal of the American Chemical Society, 70(5), 1954. https://doi.org/10.1021/ja01185a091
RAY, F E, and ALBERTSON, C E. "9.9-Difluorofluorene." Journal of the American Chemical Society vol. 70,5 (1948): 1954. doi: https://doi.org/10.1021/ja01185a091
RAY FE, ALBERTSON CE. 9.9-Difluorofluorene. J Am Chem Soc. 1948 May;70(5):1954. doi: 10.1021/ja01185a091. PMID: 18861828.
Copy Download .nbib Format: NLM
Emergency medicine: the use of activated charcoal in cases of poisoning and drug overdose.

The Western journal of medicine

Albertson TE, Olson KR, Fisher CJ.
PMID: 18749712
West J Med. 1985 Mar;142(3):385-6.

No abstract available.

Cite
Albertson TE, Olson KR, Fisher CJ. Emergency medicine: the use of activated charcoal in cases of poisoning and drug overdose. West J Med. 1985;142(3):385-6
Albertson, T. E., Olson, K. R., & Fisher, C. J. (1985). Emergency medicine: the use of activated charcoal in cases of poisoning and drug overdose. The Western journal of medicine, 142(3), 385-6.
Albertson, T E, et al. "Emergency medicine: the use of activated charcoal in cases of poisoning and drug overdose." The Western journal of medicine vol. 142,3 (1985): 385-6.
Albertson TE, Olson KR, Fisher CJ. Emergency medicine: the use of activated charcoal in cases of poisoning and drug overdose. West J Med. 1985 Mar;142(3):385-6. PMID: 18749712; PMCID: PMC1306042.
Copy Download .nbib Format: NLM
Cichlid evolution: lessons in diversification.

International journal of evolutionary biology

Koblmüller S, Albertson RC, Genner MJ, Sefc KM, Takahashi T.
PMID: 22191062
Int J Evol Biol. 2011;2011:847969. doi: 10.4061/2011/847969. Epub 2011 Dec 05.

No abstract available.

Cite
Koblmüller S, Albertson RC, Genner MJ, et al. Cichlid evolution: lessons in diversification. Int J Evol Biol. 2011;2011:847969doi: 10.4061/2011/847969.
Koblmüller, S., Albertson, R. C., Genner, M. J., Sefc, K. M., & Takahashi, T. (2011). Cichlid evolution: lessons in diversification. International journal of evolutionary biology, 2011847969. https://doi.org/10.4061/2011/847969
Koblmüller, Stephan, et al. "Cichlid evolution: lessons in diversification." International journal of evolutionary biology vol. 2011 (2011): 847969. doi: https://doi.org/10.4061/2011/847969
Koblmüller S, Albertson RC, Genner MJ, Sefc KM, Takahashi T. Cichlid evolution: lessons in diversification. Int J Evol Biol. 2011;2011:847969. doi: 10.4061/2011/847969. Epub 2011 Dec 05. PMID: 22191062; PMCID: PMC3235470.
Copy Download .nbib Format: NLM
Benzomorphans. Optically Active and trans Isomers.

Journal of medicinal chemistry

Tullar BF, Harris LS, Perry RL, Pierson AK, Soria AE, Wetterau WF, Albertson NF.
PMID: 22185138
J Med Chem. 1967 May 01;10(3):383-6. doi: 10.1021/jm00315a022.

No abstract available.

Cite
Tullar BF, Harris LS, Perry RL, et al. Benzomorphans. Optically Active and trans Isomers. J Med Chem. 1967;10(3):383-6doi: 10.1021/jm00315a022.
Tullar, B. F., Harris, L. S., Perry, R. L., Pierson, A. K., Soria, A. E., Wetterau, W. F., & Albertson, N. F. (1967). Benzomorphans. Optically Active and trans Isomers. Journal of medicinal chemistry, 10(3), 383-6. https://doi.org/10.1021/jm00315a022
Tullar, B F, et al. "Benzomorphans. Optically Active and trans Isomers." Journal of medicinal chemistry vol. 10,3 (1967): 383-6. doi: https://doi.org/10.1021/jm00315a022
Tullar BF, Harris LS, Perry RL, Pierson AK, Soria AE, Wetterau WF, Albertson NF. Benzomorphans. Optically Active and trans Isomers. J Med Chem. 1967 May 01;10(3):383-6. doi: 10.1021/jm00315a022. PMID: 22185138.
Copy Download .nbib Format: NLM
1989 sales forecasts. Global economy hits home.

Health industry today

Albertson D.
PMID: 10291406
Health Ind Today. 1989 Jan;52(1):18-20.

No abstract available.

Cite
Albertson D. 1989 sales forecasts. Global economy hits home. Health Ind Today. 1989;52(1):18-20
Albertson, D. (1989). 1989 sales forecasts. Global economy hits home. Health industry today, 52(1), 18-20.
Albertson, D. "1989 sales forecasts. Global economy hits home." Health industry today vol. 52,1 (1989): 18-20.
Albertson D. 1989 sales forecasts. Global economy hits home. Health Ind Today. 1989 Jan;52(1):18-20. PMID: 10291406.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 103 entries